Reparil-gel N gel for external use

国: アルメニア

言語: 英語

ソース: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

有効成分:

escin, diethylamine salicylate

から入手可能:

Madaus GmbH

ATCコード:

առկա չէ (M02AC)

INN（国際名）:

escin, diethylamine salicylate

投薬量:

0.01g/g+ 0.05g/g

医薬品形態:

gel for external use

パッケージ内のユニット:

40g aluminium tube

処方タイプ:

OTC

認証ステータス:

Registered

承認日:

2016-05-24

製品の特徴

Summary
of
Product
Gharacteristies
'l,,,,NAME:OF
THE:lltlEDIGlHAl'
PRODUGT
Reparil@
-
gel
N
,
,-i
AJiivE
lubst"ncbsr'Esein
{
9ro
and
2-Hydroxybenzoic
acid,
diethylazan
salt
(Diethylamine
,,,,tali
latel,5''Yo
2.
:OUALITATIVE
AND
QUANTITATIVE
COMPOSITION
100g,gel
contains:
-Actve
Substan**S,
'
,nCcih"
.'
,
','
ffi
e"*ic'acid,
diethylaean,('bietnylami:nesalicylate)
'
,
.
'1
,
'
:
. .,.
O,thei:
,ingredients;
for,ille.complete'listing
of
other
ingiedients
see
section
6.1.
,,
...
3.
PHARIIAGEUTICAT.FORM
'e[t'''
4.
ci,urcnrinmlciutnns
4.1
Therapeutic
tndications
1g
5g
,-f,,or:,topicaln
supportive
symptomatic
treatment
of
minor complaints
following
acUte
blunt
injUr're$,(B;,g.,
contusions,
sprains)
'
'tf
irOmptaints
persist
for
more
than
2 days or
deteriorate,
a
doctor
should
be consulted.
:
'
ahd
tnethod'of
administratlon
4.2
Posologry
,
{0tt'g
nng,to
0,3
mg
diethyla,mine:salicSrlate),
is
rbq,uired.
The
maximum
total
daily
dose
is
Method
of
'administfation
''
,fompieai'rce
ohllal
D0 not
ihgestl
Sp&n'i
tnin.
layel:
of
Reparil@gel
N
onto
the affected
areas
of
the
skin and
rub
the
medicine,
in
gently.
Before
appfying'a
dressing
Reparilsgel
N should
dry
for
several
minutes
on
the
skin.
Tlig,uss,,6f
'an
occlusiVe
bandage
is not
recommended.
L'mUZnUlgf*
n*iReppiii
AfuflOOSS:,
|ERITEI.1.1
B\Texte;Verlanierunq
20.08\spc-eR-aea:Rovember
-2008-1
4te.novelle.
:..,i.::,..,..,
..
...
,t'.,
'
,
SeitBilivqnS':
'
i
'
f+
",,ry
s*.
1d
.
:;:r...::r::;
i.:::
,.
/g,a/,,4,
-@
I
As
a
rule,
treatment
over
1-2
benefit
of
treatment
with
4.3
4,4
Duration
of
usel
The
treating
doctor
will determine
the
length
of
treatment.
days
is sufficient.
There
is
no evidence
for
the
therapeutic
Reparil@gel
N
beyond
this
Period.
Specific
patient
groups:
Etderly
patients:
No
special
dose adjustment
is
required.
Because
of
the
potential
side effect
profile,
elderly
patients
shOuld
be
monitored
with
particular
care.
lm
paired
renal
function:
No
dose
reduction
is
required
in
patients
with
impaired
renal
function.
lmpaired
liver
function:
No dose,
reduction
is
requi